The mechanisms of cancer cell resistance to therapy may involve NF-kB-mediated and MAPK-mediated activities generated by TLR and NF-kB-activating inflammatory factors, along with subsequent activation of STAT3-mediated maintenance of CSC. Here, NFKB1 is linked to cancer.